Thyroid Disorders


Study Finds Thyroid Inflammation Tied to Anxiety Disorders

September 19, 2020

A study from e-ECE 2020 suggests thyroid inflammation could put patients at greater risk for developing an anxiety disorder.

Nearly 1-in-3 of Physicians Could Be Overusing Thyroid Ultrasonography

August 14, 2020

A survey of more than 600 physicians found many endorsed the use of thyroid ultrasonography for clinically unsupported reasons.

Risk of Solid Cancer Death Not Influenced by Hyperthyroidism Treatment

July 24, 2020

New research is comparing the long-term risk of death from solid cancers in patients treated with radioactive iodine, antithyroid drugs, or surgery for hyperthyroidism.

Levothyroxine Fails to Provide Cardiac Benefit in Subclinical Hypothyroidism

July 21, 2020

New data disputes the findings of previous observational studies examining the effects of levothyroxine on cardiac function.

Study Reports First Known Case of Subacute Thyroiditis After COVID-19 Infection

May 21, 2020

A new case study published in The Journal of Clinical Endocrinology & Metabolism, reports on an 18-year-old patient with COVID-19 infection and subacute thyroiditis.

L-Thyroxine Ineffective In Patients With Subclinical Hypothyroidism, Study Says

May 04, 2020

The common synthetic thyroid medication L-thyroxine has been shown to be ineffective in reducing symptoms in patients with subclinical hypothyroidism (SCH), according to a study published in the Annals of Internal Medicine.

VIDEO: Teprotumumab Offers Hope for Thyroid Eye Disease Patients

April 14, 2020

New research shows teprotumumab can be a beneficial treatment for patients suffering from thyroid eye disease (TED), even across age, gender and risk factor-based subgroups. In an interview with HCPLive®, Raymond Douglas, MD, PhD, director of the Orbital and Thyroid Eye Disease Center at the Cedars-Sinai Medical Center, explained the importance of the teprotumumab in treating this patient group and how the coronavirus disease 2019 (COVID-19) might impact thyroid eye disease patients.

First Treatment for Thyroid Eye Disease Approved by FDA

January 22, 2020

The FDA announced yesterday that it has approved the first treatment for thyroid eye disease:  teprotumumab-trbw (Tepezza, Horizon Therapeutics).

Thyroid Treatment Can Aid in Adaption to Cold Environments

May 22, 2019

Restoring normal thyroid function may reverse cold-induced thermogenesis, say researchers writing in the journal Thyroid.

New Analysis Says No Need to Treat Subclinical Hypothyroidism

May 22, 2019

Adults with subclinical hypothyroidism do not need thyroid hormone therapy in most cases, states a BMJ Rapid Recommendation issued this month.